Back
Sunrise New Energy Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
33
EPOW
Sunrise New Energy
Last Price:
$1.00
Seasonality Move:
-10.15%
Buy
59
RYTM
Rhythm Pharmaceuticals
Last Price:
$63.69
Seasonality Move:
15.42%
Sell
33
Sunrise New Energy (EPOW)
is a Sell
Is Sunrise New Energy a Buy, Sell or Hold?
-
The current Sunrise New Energy [EPOW] share price is $1.00. The Score for EPOW is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
EPOW is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $62.97. The Score for RYTM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EPOW Stock Price Chart
What is Sunrise New Energy's stock price today?
-
The Sunrise New Energy share price today is $1.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EPOW is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $62.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
EPOW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 55.56 | Buy |
| Chaikin Money Flow: | -67588 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.91 - 1.01) | Buy |
| Bollinger Bands (100): | (0.84 - 0.98) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.1 | Buy |
| Relative Strength Index (14 RSI): | 62.4 | Buy |
| Chaikin Money Flow: | 1214481 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.86 - 60.56) | Buy |
| Bollinger Bands (100): | (53.06 - 59.82) | Buy |
EPOW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.99 | Buy |
| 20-day SMA: | 0.96 | Buy |
| 50-day SMA: | 0.95 | Buy |
| 200-day SMA: | 0.92 | Buy |
| 8-day EMA: | 0.98 | Buy |
| 20-day EMA: | 0.89 | Buy |
| 50-day EMA: | 0.61 | Buy |
| 200-day EMA: | 0.21 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.98 | Buy |
| 20-day SMA: | 56.91 | Buy |
| 50-day SMA: | 55.17 | Buy |
| 200-day SMA: | 53.34 | Buy |
| 8-day EMA: | 60.42 | Buy |
| 20-day EMA: | 58.11 | Buy |
| 50-day EMA: | 56.34 | Buy |
| 200-day EMA: | 52.51 | Buy |
Sunrise New Energy Earnings Growth & EPOW Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
Sunrise New Energy Technical Analysis
| Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||